Medicine
Qbrexza 2.4 g/100 g cloth
Qbrexza 2.4 g/100 g cloth is a prescription medicine containing Glycopyrronium for topical use, marketed by Journey Medical, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at room temperature 20° - 25°C (68° - 77°F), excursions permitted to 15°…
Key facts
- Active ingredient (INN)
- Glycopyrronium
- Brand
- Qbrexza
- Strength
- 2.4 g/100 g
- Dosage form
- Cloth
- Route
- Topical
- Packs
- 30 pouches
- Marketing authorisation holder
- Journey Medical
- Manufacturer
- Journey Medical
- Origin register
- US FDA, United States
- Storage
- Store at room temperature 20° - 25°C (68° - 77°F), excursions permitted to 15° - 30°C (59° - 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A03AB02 Glycopyrrolate
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 28 June 2018
- Identifiers
- RxCUI 2054118, 2054120DailyMed set ID 5b372650-e56e-47a5-93e2-c0c292017059NDC 69489-411Application NDA210361
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 pouch in 1 carton / 2.8 g in 1 pouch | 69489-411-30 | Journey Medical | 3 December 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Glycopyrronium is an anticholinergic indicated for topical treatment of primary axillary hyperhidrosis in adult and pediatric patients 9 years of age and older. It is available as cloths for topical use. MedsAcross supplies Glycopyrronium for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about GlycopyrroniumFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Qbrexza prescribing information (Journey Medical) · U.S. National Library of Medicine, DailyMed
- Seebri Breezhaler: European public assessment report (EPAR) · European Medicines Agency
- Sialanar: European public assessment report (EPAR) · European Medicines Agency
Need Qbrexza 2.4 g/100 g cloth for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.